Dekel Gelbman and How Machine Learning Is Changing Rare Disease Diagnosis
 EPISODE SUMMARY Harry's guest is Dekel Gelbman, founding CEO of FDNA. The company uses a combination of computer vision, deep learning, and other artificial intelligence techniques to improve and accelerate diagnostics and therapeutics for children with rare diseases. Transcript D